Concert Pharma (CNCE) Earnings 'Uneventful' Says Mizuho, Likes The CTP-692 Program
Tweet Send to a Friend
Mizuho Securities maintains Neutral on Concert Pharmaceuticals (NASDAQ: CNCE) price target of $23.00Concert Pharma (NASDAQ: CNCE).Analyst Difel Yang called the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
